“…Since 2009, an extraordinary number of field and laboratory studies on canine leishmaniasis in the Americas have been published in international literature. These include epidemiological studies focused on prevalence and risk factors (e.g., [ 67 , 68 ]), studies validating new diagnostic tools (e.g., [ 69 ]), and clinical trials assessing the efficacy or effectiveness of therapeutic protocols (e.g., [ 70 ]) and prevention and control strategies (e.g., [ 71 , 72 ]). The unified efforts of scientists, nongovernmental organizations [e.g., the Brasileish group ( https://www.brasileish.com.br )], and public health authorities effectively contributed to positively changing our practices in terms of the diagnosis, treatment, prevention, and control of canine leishmaniasis, particularly in Brazil, where mass culling of seropositive dogs is no longer a common practice, 4% deltamethrin-impregnated dog collars are often applied to dogs in high-risk areas, and miltefosine is now licensed for use in dogs [ 55 , 73 , 74 ].…”